20 June 2008
IHE releases new profiles using HL7 CCD templates and other HL7 CDA profiles, HL7v3 messages, and HL7v2 messages.
The Antepartum Record makes use of templates from the HL7 Continuity of Care Document (CCD), and the CDA4CDT History and Physical document. The Care Management profile makes use again of the Care Record and Care Record Query DSTU's. The Cancer Registry Pathology Report and Immunization Content make use of the HL7 V2.3.1 messages for communicating information to cancer and immunization registries. The Immunization Content profile also makes use of Care Record to support the communication of immunization information using a V3 message.
There have been updates to the QED profile, which simplifies this profile and its use of the HL7 Care Record and Care Record Query DSTUs.
New Technical Framework supplement documents and whitepapers have been published for public comment for the Patient Care Coordination (PCC) Domain
These supplements are available for download at http://static.ihe.net/Technical_Framework/index.cfm#pcc. To be considered for incorporation in the Trial Implementation versions of these supplements, comments must be submitted by July 18, 2008. Early submission will be greatly appreciated.
Quality, Research and Public Health (QRPH) Domain:
These supplements are available for download at http://static.ihe.net/Technical_Framework/index.cfm#quality. To be considered for incorporation in the Trial Implementation versions of these supplements, comments must be submitted by July 18, 2008. Early submission will be greatly appreciated.
IT Infrastructure (ITI) Domain:
These supplements are available for download at http://www.ihe.net/Technical_Framework/index.cfm#IT. To be considered for incorporation in the Trial Implementation versions of these supplements, comments must be submitted by July 9, 2008. Early submission will be greatly appreciated.
Patient Care Devices (PCD) Domain:
These supplements are available for download at http://www.ihe.net/Technical_Framework/index.cfm#pcd. To be considered for incorporation in the Trial Implementation versions of these supplements, comments must be submitted by July 7, 2008. Early submission will be greatly appreciated.
Last modified 20/06/08